Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases
Yuming Sun, Qian Zhou, Lorraine Edna Onzere, Yating Dian, Meng Yu, Daishi Li, Furong Zeng, Shaorong Lei, Guangtong Deng
Topics & Concepts
ReceptorAutoimmune diseaseGlucagon-like peptide 1 receptorMedicineAgonistImmunologyInternal medicineAntibodyDiabetes Treatment and ManagementDiabetes and associated disordersThyroid Disorders and Treatments